Roche ($RHHBY) said it wouldn't extend its $51-per-share bid for Illumina, after voting tallies indicated that shareholders backed the gene-sequencing company's incumbent board candidates, rather than Roche's slate. Release
Roche ($RHHBY) said it wouldn't extend its $51-per-share bid for Illumina, after voting tallies indicated that shareholders backed the gene-sequencing company's incumbent board candidates, rather than Roche's slate. Release